Flaviviruses - Yin Yang of Heterologous T Cell Immunity
黄病毒-异源T细胞免疫的阴阳
基本信息
- 批准号:7701544
- 负责人:
- 金额:$ 43.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AvidityBiological AssayCD8B1 geneCategoriesCell Culture TechniquesCell LineCell SeparationCellular ImmunityClinicalCollaborationsDataDengue Hemorrhagic FeverDengue VirusDiseaseEncephalitis VirusesEndothelial CellsEpitopesFamilyFlaviviridaeFlavivirusFlavivirus InfectionsFlow CytometryGenerationsHumanImmuneImmune responseImmunityImmunizationIn VitroIncidenceIndividualInfectionJapanese Encephalitis VirusesJapanese encephalitis virusMaintenanceMeasuresMemoryMethodsModelingOutcomePathogenesisPathologyPatternPeptide/MHC ComplexPeptidesPrimatesReagentResearch Project GrantsRoleSamplingSerotypingSignal TransductionSouth AmericaSpecificitySystemT-LymphocyteT-Lymphocyte EpitopesTransgenic MiceVaccinesVariantViralViral Load resultVirusVirus DiseasesWest Nile virusYellow FeverYellow fever virusYin-Yangassay developmentcross reactivitydisease characteristichemorrhagic fever virusimmunopathologyin vivoinsightmetermouse modelnovelpathogenresponsesecondary infectiontechnology development
项目摘要
The family Flaviviridae includes hemorrhagic fever viruses (e.g. dengue viruses, yellow fever virus) and
encephalitis viruses (e.g. West Nile virus, Japanese encephalitis viruses). The long-term objective of this
project is to determine the effect of flavivirus-specific CD4+ and CD8+ T cell responses induced by primary
flavivirus infection on the immune response to subsequent infection with related flaviviruses.
In Specific Aim 1, we will characterize effector responses, TCR avidity and signaling to homologous and
heterologous virus CD4+ and CD8+ T cell epitopes in primary flavivirus-immune individuals.
In Specific Aim 2, we will generate primary flavivirus CD4+ and CD8+ T cell responses to variant epitopes
from flavivirus-naTve individuals and in human HLA transgenic mice. We will characterize cross-reactivity as
in Aim 1 and will compare our findings in vitro to those generated in vivo.
In Specific Aim 3, we will determine the biologic relevance of our in vitro findings. We will define variant
specific responses in humans with sequential flavivirus infections. Using human HLA transgenic mice, we will
model primary and secondary responses using peptide immunization followed by subclinical West Nile virus
infection. Lastly, in collaboration with Project 2, we will determine the effect of variant T cell stimulation of
human T cells on primary human endothelial cells.
These studies will help to elucidate mechanisms of cross-protection and may give insights into disease
pathogenesis.
黄病毒科包括出血热病毒(例如登革热病毒、黄热病病毒)和
脑炎病毒(例如西尼罗河病毒、日本脑炎病毒)。长期目标是
项目是确定黄病毒特异性CD4+和CD8+ T细胞应答的影响,
黄病毒感染对随后感染相关黄病毒的免疫应答的影响。
在特异性目标1中,我们将表征效应子应答、TCR亲合力和对同源和
异源病毒CD4+和CD8+ T细胞表位在原代黄病毒免疫个体中的表达。
在特异性目标2中,我们将产生对变体表位的初级黄病毒CD4+和CD8+ T细胞应答
来自黄病毒天然个体和人HLA转基因小鼠。我们将交叉反应性描述为
在目标1中,并将我们在体外的发现与体内产生的结果进行比较。
在具体目标3中,我们将确定我们体外发现的生物学相关性。我们将定义变量
在连续黄病毒感染的人类中的特异性反应。使用人类HLA转基因小鼠,我们将
使用肽免疫随后亚临床西尼罗河病毒的模型初级和次级应答
感染最后,与项目2合作,我们将确定变体T细胞刺激对
人T细胞对原代人内皮细胞的作用。
这些研究将有助于阐明交叉保护的机制,并可能使人们深入了解疾病
发病机制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sharone Green其他文献
Sharone Green的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sharone Green', 18)}}的其他基金
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 43.09万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 43.09万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 43.09万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 43.09万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 43.09万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 43.09万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 43.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 43.09万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 43.09万 - 项目类别:
Postdoctoral Fellowships